Literature DB >> 22831155

Neuroinflammation: a contributing factor to the pathogenesis of cancer cachexia.

Alessandro Laviano1, Marilia Seelaender, Serena Rianda, Renata Silverio, Filippo Rossi Fanelli.   

Abstract

The clinical journey of cancer patients is frequently complicated by the development of a complex and multifaceted syndrome, the main features of which are reduced appetite, decreased food intake, progressive weight loss, and wasting of muscle mass and adipose tissue, which is not prevented by the provision of calories and proteins. This syndrome, termed Cachexia, is responsible for increased morbidity, reduced survival, and impinged quality of life of cancer patients. The pathogenesis is complex and involves deranged metabolism of peripheral tissues and profound alterations of brain neurochemistry. Recent studies indicate that brain neurochemistry is perturbed during tumor growth by cancer-induced increased intrahypothalamic expression of proinflammatory cytokines. The attending neurochemical chaos mediates the anorexigenic behavioral responses associated to cancer cachexia, but recent data seem to suggest that neuronal output also may be involved in the metabolic changes occurring at the peripheral level.

Entities:  

Mesh:

Year:  2012        PMID: 22831155     DOI: 10.1615/critrevoncog.v17.i3.20

Source DB:  PubMed          Journal:  Crit Rev Oncog        ISSN: 0893-9675


  6 in total

1.  Hypothalamic eIF2α signaling regulates food intake.

Authors:  Anne-Catherine Maurin; Alexandre Benani; Anne Lorsignol; Xavier Brenachot; Laurent Parry; Valérie Carraro; Christophe Guissard; Julien Averous; Céline Jousse; Alain Bruhat; Cédric Chaveroux; Wafa B'chir; Yuki Muranishi; David Ron; Luc Pénicaud; Pierre Fafournoux
Journal:  Cell Rep       Date:  2014-01-30       Impact factor: 9.423

2.  Cancer cachexia: muscle physiology and exercise training.

Authors:  Claudio L Battaglini; Anthony C Hackney; Matthew L Goodwin
Journal:  Cancers (Basel)       Date:  2012-11-29       Impact factor: 6.639

3.  Eating-related distress and need for nutritional support of families of advanced cancer patients: a nationwide survey of bereaved family members.

Authors:  Koji Amano; Isseki Maeda; Tatsuya Morita; Yoshiro Okajima; Takashi Hama; Maho Aoyama; Yoshiyuki Kizawa; Satoru Tsuneto; Yasuo Shima; Mitsunori Miyashita
Journal:  J Cachexia Sarcopenia Muscle       Date:  2016-02-15       Impact factor: 12.910

4.  C-reactive protein, symptoms and activity of daily living in patients with advanced cancer receiving palliative care.

Authors:  Koji Amano; Isseki Maeda; Tatsuya Morita; Mika Baba; Tomofumi Miura; Takashi Hama; Ichiro Mori; Nobuhisa Nakajima; Tomohiro Nishi; Hiroki Sakurai; Satofumi Shimoyama; Takuya Shinjo; Hiroto Shirayama; Takeshi Yamada; Shigeki Ono; Taketoshi Ozawa; Ryo Yamamoto; Naoki Yamamoto; Hideki Shishido; Hiroya Kinoshita
Journal:  J Cachexia Sarcopenia Muscle       Date:  2017-03-01       Impact factor: 12.910

5.  Tumour-derived transforming growth factor-β signalling contributes to fibrosis in patients with cancer cachexia.

Authors:  Joanna D C C Lima; Estefania Simoes; Gabriela de Castro; Mychel Raony P T Morais; Emidio M de Matos-Neto; Michele J Alves; Nelson I Pinto; Raquel G Figueredo; Telma M T Zorn; Aloísio S Felipe-Silva; Flavio Tokeshi; José P Otoch; Paulo Alcantara; Fernanda J Cabral; Emer S Ferro; Alessandro Laviano; Marilia Seelaender
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-07-04       Impact factor: 12.910

6.  Cancer cachexia induces morphological and inflammatory changes in the intestinal mucosa.

Authors:  Raquel G F Costa; Paula L Caro; Emídio M de Matos-Neto; Joanna D C C Lima; Katrin Radloff; Michele J Alves; Rodolfo G Camargo; Ana Flávia M Pessoa; Estefania Simoes; Patrícia Gama; Denise C Cara; Aloísio S F da Silva; Welbert O Pereira; Linda F Maximiano; Paulo S M de Alcântara; José P Otoch; Giorgio Trinchieri; Alessandro Laviano; Maurizio Muscaritoli; Marília Seelaender
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-07-15       Impact factor: 12.910

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.